Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?

Eur J Clin Microbiol Infect Dis. 2023 Jul;42(7):917-918. doi: 10.1007/s10096-023-04612-x. Epub 2023 Apr 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacteremia* / drug therapy
  • Bacteremia* / microbiology
  • Ceftriaxone / therapeutic use
  • Humans
  • Methicillin
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / microbiology
  • Staphylococcus aureus

Substances

  • Ceftriaxone
  • Methicillin
  • Anti-Bacterial Agents